Benzinga
Benzinga
Benzinga
sábado, septiembre 26

CareDx Inc

CDNANASDAQ
Trade with Public
Trade with Public
$63.68
2.313.76%
al cierre: Sep 25, 5:00 PM EST
$63.93
0.250.39%
After hour: 7:46 PM EST
PRO
¿Por qué se mueve?:CareDx shares are trading higher after BTIG maintained its Buy rating on th...
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

CareDx Analyst Price Targets

Wall Street analyst price targets and consensus rating for CareDx (CDNA).

Price Target Range — 12 Quarters

Analyst Consensus — 8 Analysts

5Buy
3Hold
Consensus RatingBuy# Analysts8Avg. Consensus PT$39Upside to Avg. PT-39.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →
DateFirmAnalystActionRating ChangePrice Target
Sep 24, 2026BTIGMark MassaroPT RaiseBuy$60→$74
Sep 2, 2026Canaccord GenuityKyle MiksonInitiateBuy$65
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Maintains Buy on CareDx, Raises Price Target to $74

BTIG analyst Mark Massaro maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $60 to $74.
Benzinga Newsdesk

Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently

CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.
Vandana Singh

PRO
Canaccord Genuity Initiates Coverage On CareDx with Buy Rating, Announces Price Target of $65

Canaccord Genuity analyst Kyle Mikson initiates coverage on CareDx (NASDAQ:CDNA) with a Buy rating and announces Price Target of $65.
Benzinga Newsdesk

PRO
BTIG Maintains Buy on CareDx, Raises Price Target to $60

BTIG analyst Mark Massaro maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $45 to $60.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Neutral on CareDx, Maintains $46 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral and maintains $46 price target.
Benzinga Newsdesk

PRO
BTIG Maintains Buy on CareDx, Raises Price Target to $45

BTIG analyst Mark Massaro maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $28 to $45.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved